Nye donationer fra global fond mod aids, tuberkulose og malaria

Hedebølge i Californien. Verdens klimakrise har enorme sundhedsmæssige konsekvenser. Alligevel samtænkes Danmarks globale klima- og sundhedsindsats i alt for ringe grad, mener tre  debattører.


Foto: Kevin Carter/Getty Images
Redaktionen

The Board of the Geneva-based Global Fund to Fight AIDS, Tuberculosis and Malaria Tuesday approved renewed funding worth up to 119 million US dollar for the first batch of grants to reach the two year mark.

The Global Fund approves funding for five years, but initially commits funding for only the first two year phase. The end of this first phase is a critical milestone in the lifespan of the grants, as well as for the performance-based funding model used by the Global Fund.

One of the Global Funds key operating principles is that it will only fund programs that successfully contribute to the treatment and/or prevention of HIV/AIDS, tuberculosis and malaria. All grant agreements include performance indicators and targets (agreed upon by both the Principal Recipient and the Global Fund) for the measurement of program success.

To ensure that grant funding goes only where it is being managed and spent effectively, the Global Fund uses the Phase 2 review process as a checkpoint. Only grants with satisfactory performance measured against agreed targets for the first two years of a grants life continue to receive funding for their remaining years.

Each of the 21 grants approved Tuesday for continued funding was evaluated for tangible, verified, and significant results in Phase 1.  With the approval of these funds, grant recipients in 16 countries will receive up to 119 million dollar for the second phase of the grants spanning years three to five.

The Global Fund now has 3,1 billion US dollar approved for the first two years of grants in 127 countries. The 21 grants just approved for continued funding represent the first wave of evaluation at the two-year mark of the more than 300 grants now being financed by the Global Fund.

New grant agreements have been signed almost monthly for the last two years, so evaluation of maturing grants will now become a regular part of Global Fund business operations. 

A Frequently Asked Questions sheet on the Phase 2 review process can be found on the Global Fund website at: www.theglobalfund.org. The Global Funds information management system compiles key information generated for each grant program into a Grant Performance Report on the life of the grant to date. Grant Performance Reports are posted on the Global Funds website at
www.theglobalfund.org/en/funds_raised/performance/ .

The following are the grants for which Phase 2 funding has been approved, as well as the amount recommended as an upper ceiling for phase 2 funding. All amounts are stated in US dollar.

Benin, Malaria – Round 1: 583.965 (US dollar)

Burundi, HIV – Round 1: 3,780.000

China, TB – Round 1: 22,700.000

China, Malaria – Round 1: 2,882.997

Ghana, HIV – Round 1: 9,204.744

Ghana, TB – Round 1: 3,350.115

Haiti,  HIV – Round 1: 35,547.100

Honduras, TB – Round 1: 2,806.514

Honduras, Malaria – Round 1: 3,108.090

India, TB – Round 1: 3,134.000

Lao PDR, Malaria – Round 1: 9,553.935

Madagascar, Malaria – Round 1: 249.764

Madagascar, HIV – Round 2: 756.425

Madagascar, HIV – Round 2: 1,992.068

Moldova, TB/HIV – Round 1: 6,461.106

Mongolia, TB – Round 1: 1,086.000

Morocco, HIV – Round 1: 4,499.948

Panama, TB – Round 1: 130.000

Rwanda, TB/HIV – Round 1: 6,231.778

Tajikistan, HIV – Round 1: 950.725

Tanzania/Zanzibar, Malaria – Round 1: 371.860

The Global Fund on the Global Fund

The Global Fund is a unique global public-private partnership dedicated to attracting and disbursing additional resources to prevent and treat AIDS, tuberculosis and malaria.

This partnership between governments, civil society, the private sector and affected communities represents a new approach to international health financing. The Fund works in close collaboration with other bilateral and multilateral organizations to supplement existing efforts dealing with the three diseases.

The Global Fund is an independent private foundation under Swiss law, governed by an international Board. Apart from a high standard of technical quality, the Global Fund attaches no conditions to any of its grants.

It is not an implementing agency. It relies on local ownership and planning to ensure that new resources are directed to programs on the frontline of this global effort, reaching those most in need.

Its performance-based approach to grant-making – where grants are only disbursed if progress has been measured and verified – is designed to ensure that funds are used efficiently and create lasting change for people and communities.

Further information on the work of the Global Fund is available at www.theglobalfund.org or contact Rosie Vanek, Communications Officer, at 0041 22 791 5951, [email protected]